Assays | Mode of action | Reference compound | EC value | Reference method |
---|---|---|---|---|
ERα-GeneBLAzer | Estrogenicity | 17β-Estradiol (E2) | EC10 | [15] |
GR-GeneBLAzer | Glucocorticogenic activity | Dexamethasone | EC10 | |
AR-GeneBLAzer | Androgenicity | Metribolone (R1881) | EC10 | |
Anti AR-GeneBLAzer | Anti androgenicity | Cyproterone acetate (antagonist) Metribolone R1881 (agonist) | ECSR0.2 | |
PR-GeneBLAzer | Progestagenic activity | Promegestone | EC10 | |
Anti PR-GeneBLAzer | Anti progestagenic activity | Mifepristone RU-486 (antagonist) Promegestone (agonist) | ECSR0.2 | |
AREc32 | Oxidative stress response (adaptive stress response) | t-Butyl-hydroquinone (tBHQ) | ECIR1.5 | |
PPARγ-GeneBLAzer | Peroxisome proliferation activation | Rosiglitazone | EC10 | [30] |
AhR-CALUX | Aryl hydrocarbon receptor induction | 2,3,7,8-Tetrachlorodibenzodioxin (TCDD) | EC10 |